| Literature DB >> 29731744 |
Laura Giovati1, Claudia Santinoli1, Carlo Mangia2, Alice Vismarra2, Silvana Belletti3, Tiziana D'Adda4, Claudia Fumarola5, Tecla Ciociola1, Cristina Bacci2, Walter Magliani1, Luciano Polonelli1, Stefania Conti1, Laura H Kramer2.
Abstract
The killer peptide KP is a synthetic decapeptide derived from the sequence of the variable region of a recombinant yeast killer toxin-like microbicidal single-chain antibody. KP proved to exert significant activities against diverse microbial and viral pathogens through different mechanisms of action, but little is known of its effect on apicomplexan protozoa. The aim of the present study was to evaluate the in vitro activity of KP against Toxoplasma gondii, a globally widespread protozoan parasite of great medical interest. The effect of KP treatment and its potential mechanism of action on T. gondii were evaluated by various methods, including light microscopy, quantitative PCR, flow cytometry, confocal microscopy, and transmission electron microscopy. In the presence of KP, the number of T. gondii tachyzoites able to invade Vero cells and the parasite intracellular proliferation were significantly reduced. Morphological observation and analysis of apoptotic markers suggested that KP is able to trigger an apoptosis-like cell death in T. gondii. Overall, our results indicate that KP could be a promising candidate for the development of new anti-Toxoplasma drugs with a novel mechanism of action.Entities:
Keywords: TUNEL; anti-Toxoplasma agents; apoptosis; killer peptide KP; mitochondrial potential; transmission electron microscopy
Year: 2018 PMID: 29731744 PMCID: PMC5920037 DOI: 10.3389/fmicb.2018.00753
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Effect of KP treatment on infection index and intracellular proliferation of T. gondii in Vero cells.
| Treatment | Infection indexa | Intracellular proliferationb | ||
|---|---|---|---|---|
| Mean ± | % Inhibition | Mean ± | % Inhibition | |
| Controlc | 175 ± 3 | - | 3368 ± 1123 | - |
| KP 25 μg/mL | 118 ± 22*** | 33 | 1557 ± 225** | 54 |
| KP 50 μg/mL | 106 ± 16*** | 39 | 858 ± 130*** | 75 |
| KP 100 μg mL | 42 ± 5*** | 76 | 253 ± 100*** | 92 |
| KP 200 μg/mL | 22 ± 17*** | 87 | 181 ± 45*** | 95 |
| SP 200 μg/mL | 158 ± 7 | 9 | 2315 ± 779 | 31 |